[1]吴 刚,陈腊梅.附桂骨痛片联合艾瑞昔布片及氟比洛芬巴布膏 治疗膝骨关节炎的临床研究[J].医学信息,2019,32(14):158-160.[doi:10.3969/j.issn.1006-1959.2019.14.053]
　WU Gang,CHEN La-mei.Clinical Study on Treatment of Knee Osteoarthritis with Fuguigutong Tablets Combined with Ericoxib Tablets and Flurbiprofen Bab Cream[J].Journal of Medical Information,2019,32(14):158-160.[doi:10.3969/j.issn.1006-1959.2019.14.053]
点击复制

附桂骨痛片联合艾瑞昔布片及氟比洛芬巴布膏 治疗膝骨关节炎的临床研究()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年14期
页码:
158-160
栏目:
中医中药
出版日期:
2019-07-15

文章信息/Info

Title:
Clinical Study on Treatment of Knee Osteoarthritis with Fuguigutong Tablets Combined with Ericoxib Tablets and Flurbiprofen Bab Cream
文章编号:
1006-1959（2019）14-0158-03
作者:
吴 刚; 陈腊梅
天门市第一人民医院药剂科，湖北 天门 431700
Author(s):
WU Gang; CHEN La-mei
Department of Pharmacy,the First People's Hospital of Tianmen City,Tianmen 431700,Hubei,China
关键词:
附桂骨痛片; 艾瑞昔布; 氟比洛芬巴布膏; 膝骨关节炎
Keywords:
Key words：Fuguigutongtong tablets; Ericoxib tablets; Flurbiprofen bab cream; Knee osteoarthritis
分类号:
R684.3
DOI:
10.3969/j.issn.1006-1959.2019.14.053
文献标志码:
A
摘要:
目的 观察附桂骨痛片联合艾瑞昔布片和氟比洛芬巴布膏治疗膝骨关节炎（KOA）的临床疗效和安全性。方法 选取2017年7月~2018年5月在我院就诊的KOA患者284例，按照随机数字表法分为A组和B组，各142例。A组患者给予口服艾瑞昔布片联合外用氟比洛芬巴布膏治疗，B组患者在A组基础上加服附桂骨痛片，两组患者均以8周为1个疗程。比较两组患者治疗前后的临床疗效及西安大略和麦克马斯特大学量表（WOMAC）评分、视觉模拟评分法（VAS）评分、中医证候评分、实验室检查指标、不良反应发生情况。结果 B组治疗总有效率高于A组（90.14% vs 77.46%），差异有统计学意义（P＜0.05）。治疗后，两组患者WOMAC评分、VAS评分、中医证候积分，以及CRP、ESR、MMP-1、MMP-3水平均低于治疗前，且B组低于A组，差异均有统计学意义（P＜0.05）。治疗中两组患者均无明显不良反应发生。结论 附桂骨痛片联合艾瑞昔布片及氟比洛芬巴布膏可缓解关节疼痛，改善KOA患者临床症状，临床疗效好，且安全性高。
Abstract:
Abstract：Objective To observe the clinical efficacy and safety of Fuguigutong Tablets combined with ericoxib tablets and flurbiprofen bab cream in the treatment of knee osteoarthritis (KOA). Methods A total of 284 patients with KOA who were admitted to our hospital from July 2017 to May 2018 were enrolled.According to the random number table,they were divided into group A and group B,each with 142 cases.Patients in group A were treated with oral ericoxib tablets combined with topical flurbiprofen bab cream.Group B was additionally given Fuguigutong tablets.All patients were treated with 8 weeks as a course of treatment.The clinical efficacy of the two groups of patients before and after treatment and the Western Ontario and McMaster University Scale (WOMAC) score,visual analog scale (VAS) score,TCM syndrome score,laboratory test indicators,adverse reactions occurred. Results The total effective rate of group B was higher than that of group A (90.14% vs 77.46%),the difference was statistically significant (P<0.05). After treatment, the WOMAC score, VAS score, TCM syndrome score, and CRP, ESR, MMP-1, and MMP-3 levels in the two groups were lower than those before treatment, and the group B was lower than the group A, the difference was statistically significant (P<0.05). There were no significant adverse reactions in the two groups of patients during the treatment. Conclusion The combination of Fuguigutong tablets combined with irbisoxib tablets and flurbiprofen bab cream can relieve joint pain, improve clinical symptoms of KOA patients, and has good clinical efficacy and high safety.

参考文献/References:

[1]陈峰,石晓兵.膝骨性关节炎临床分期的现状和研究进展[J].广西医科大学学报,2018,35(3):412-415. [2]Egloff C,Hügle T,Valderrabano V.Biomechanics and pathomechanisms of osteoarthritis[J].Swiss Med Wkly,2012(142):w13583. [3]雷光华,王坤正.骨关节炎诊疗指南(2018年版)解读[J].中华骨科杂志,2018,38(12):716-717. [4]薛浩,刘岩,冉博,等.膝关节骨性关节炎治疗现状[J].医学综述,2018,24(2):321-325,330. [5]中华医学会风湿病学分会.骨关节炎诊断及治疗指南[J].中华风湿病学杂志,2010,14(6):416-419. [6]中华中医药学会.中医内科常见疾病诊疗指南[M].北京:中国中医药出版社,2008:129-131. [7]Pollard B,Johnston M,Dixon D.Exploring differential itemfunctioning in the Western Ontario and McMaster Universities Osteoarthritis Index(WOMAC)[J].BMC Musculoskelet Disord,2012,13(1):265. [8]张美玲,陈谦艳.独活寄生汤联合艾灸及塞来昔布治疗膝骨关节炎30例[J].风湿病与关节炎,2014,3(5):13-15. [9]郑筱萸.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:349-353. [10]叶华,左晓霞,古洁若,等.氟比洛芬巴布膏治疗膝骨关节炎疼痛的全国多中心随机开放阳性药对照临床研究[J].中华风湿病学杂志,2012,16(9):606-610. [11]郑西希,郑文洁,张奉春.艾瑞昔布治疗膝骨关节炎的Ⅳ期多中心开放临床试验[J].中华风湿病学杂志,2016,20(11):730-733. [12]黎友允.乌头汤治疗阳虚寒凝型膝关节骨性关节炎随机平行对照研究[J].实用中医内科杂志,2013,27(2):99-100.

更新日期/Last Update: 2019-07-15